drugset / Trial / NCT00198328

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

NCT00198328

Phase 3 Terminated 84 enrolled Inovio Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate Medpulser electroporation (EPT) with bleomycin with regard to local tumor recurrence, disease-free survival, and overall survival rates versus surgery in recurrent or secondary primary squamous cell carcinoma (SCC) of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx or larynx.

Timeline

Start
2004-11
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown 1 unknown Other

Indications